Agenus
AGEN
#8289
Rank
โ‚ฌ0.28 B
Marketcap
6,39ย โ‚ฌ
Share price
11.02%
Change (1 day)
75.29%
Change (1 year)

EPS for Agenus (AGEN)

EPS in 2023 (TTM): -0,80ย โ‚ฌ

According to Agenus 's latest financial reports the company's current EPS (TTM) is 1,80ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,71ย โ‚ฌ a decrease over its 2021 EPS that were of -0,16ย โ‚ฌ.

EPS history for Agenus from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,80ย โ‚ฌ13.91%
2022-0,71ย โ‚ฌ338.89%
2021-0,16ย โ‚ฌ-82.86%
2020-0,94ย โ‚ฌ32.91%
2019-0,71ย โ‚ฌ-45.89%
2018-1,30ย โ‚ฌ19.67%
2017-1,09ย โ‚ฌ-17.01%
2016-1,31ย โ‚ฌ27.83%
2015-1,03ย โ‚ฌ69.12%
2014-0,61ย โ‚ฌ-40.87%
2013-1,03ย โ‚ฌ134.69%
2012-0,44ย โ‚ฌ-59.5%
2011-1,08ย โ‚ฌ-14.18%
2010-1,26ย โ‚ฌ-41.25%
2009-2,14ย โ‚ฌ-20%
2008-2,68ย โ‚ฌ-38.27%
2007-4,34ย โ‚ฌ-29.57%
2006-6,16ย โ‚ฌ-29.88%
2005-8,79ย โ‚ฌ29.13%
2004-6,81ย โ‚ฌ-25.29%
2003-9,11ย โ‚ฌ-0.58%
2002-9,16ย โ‚ฌ-33.72%
2001-13,83ย โ‚ฌ35.79%
2000-10,18ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,97ย โ‚ฌ 230.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,89ย โ‚ฌ-50.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,04ย โ‚ฌ 123.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,57ย โ‚ฌ 42.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-3,88ย โ‚ฌ-315.35%๐Ÿ‡บ๐Ÿ‡ธ USA